NCT00510536

Treatment of Mild to Moderate Joint Pain in Patients With Chronic Plaque Psoriasis Receiving Efalizumab

A Phase 4 Study to Assess the Practical Management of Mild to Moderate Arthritic or Arthralgic Events in Patients With Chronic Plaque Psoriasis Receiving Efalizumab

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 50 (estimated)
• Sponsor: Probity Medical Research · Network
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to evaluate tolerability and effectiveness of conventional treatment for mild to moderate arthritic or arthralgic symptoms while subjects are being treated with efalizumab for psoriasis.

Detailed description

The study objective is to demonstrate that mild to moderate arthritis or arthralgia may be controlled using conventional therapy while being treated with efalizumab, without loss of efficacy.

Conditions

• Arthritis
• Arthralgia

Interventions

Type	Name	Description
DRUG	Acetaminophen	dose to be determined by investigator
DRUG	NSAID	dose to be determined by investigator

Timeline

• Start date: 2007-07-01
• Primary completion: 2008-10-01
• Completion: 2008-10-01
• First posted: 2007-08-02
• Last updated: 2009-04-10

Locations

1 site across 1 country: Canada